SCHEMBL7739010

SCHEMBL7739010

CCCCC(=O)Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1cccc(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.47
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
FABP4 P15090 1/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MAPT P10636 2/20 0.40
THRB P10828 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ADORA1 P30542 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739024 0.90 KDR (0.50) KDRFLT1FLT4FABP4HPGD
SCHEMBL7744194 0.88 ADORA1 (0.46) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7739017 0.86 KDR (0.62) KDRKMT2AFLT1FLT4FABP4
SCHEMBL7739007 0.86 KDR (0.51) KDRTDP1L3MBTL1KMT2AMTNR1A
SCHEMBL7744660 0.86 KDR (0.44) KDRFLT1FLT4FABP4HPGD
SCHEMBL7744655 0.85 HPGD (0.50) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744165 0.85 HPGD (0.44) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744044 0.85 HPGD (0.44) KDRFLT1FLT4HPGDSMN1; SMN2
SCHEMBL7744076 0.84 KDR (0.46) KDRFLT1FLT4FABP4HPGD
SCHEMBL7744794 0.84 PKM (0.43) KDRKMT2AMTNR1AMTNR1BFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed